IPH.PA

Innate Pharma S.A. [IPH.PA] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

IPH.PA Stock Summary

Top 10 Correlated ETFs

IPH.PA


Top 10 Correlated Stocks

IPH.PA


In the News

IPH.PA Financial details

Company Rating
Strong Buy
Market Cap
175.02M
Income
-71.12M
Revenue
80.31M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
191
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-2.07
Forward P/E
3.53
PEG
0.72
P/S
4.18
P/B
3.79
P/C
-
P/FCF
-10.24
Quick Ratio
3.38
Current Ratio
3.38
Debt / Equity
0.77
LT Debt / Equity
0.6
-
-
EPS (TTM)
-0.89
EPS next Y
0.62
EPS next Q
-
EPS this Y
-92.47%
EPS next Y
-169.21%
EPS next 5Y
-115.76%
EPS last 5Y
-21.21%
Revenue last 5Y
-5.53%
Revenue Q/Q
-53.15%
EPS Q/Q
-660.75%
-
-
-
-
SMA20
-5.6%
SMA50
-12.75%
SMA100
-5.19%
Inst Own
0.2%
Inst Trans
0%
ROA
-48%
ROE
-123%
ROC
-0.07%
Gross Margin
100%
Oper. Margin
-23%
Profit Margin
-200%
Payout
-
Shs Outstand
80.84M
Shs Float
55.37M
-
-
-
-
Target Price
-
52W Range
2.11-3.345
52W High
-27%
52W Low
+9.5%
RSI
43.38
Rel Volume
0.44
Avg Volume
85.47K
Volume
37.83K
Perf Week
-1.35%
Perf Month
-5.19%
Perf Quarter
-3.95%
Perf Half Y
-12.75%
-
-
-
-
Beta
0.659
-
-
Volatility
0.01%, 0.07%
Prev Close
0%
Price
2.19
Change
0%

IPH.PA Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.030.720.150.630.65
Net income per share
-0.31-0.9-0.74-1.25-0.09
Operating cash flow per share
0.52-0.66-0.73-0.24-0.4
Free cash flow per share
-0.46-0.8-0.75-0.26-0.43
Cash per share
3.271.921.511.281.15
Book value per share
3.251.981.350.680.65
Tangible book value per share
1.81.390.80.660.65
Share holders equity per share
3.251.981.350.680.65
Interest debt per share
0.280.330.610.60.52
Market cap
398.77M273.27M353.81M261.27M210.79M
Enterprise value
214.61M155.57M294.3M219.3M180.07M
P/E ratio
-19.02-3.86-5.98-2.64-27.85
Price to sales ratio
5.784.8129.215.264.06
POCF ratio
11.42-5.27-6.05-13.64-6.47
PFCF ratio
-13.08-4.33-5.92-12.89-6.04
P/B Ratio
1.831.753.294.824.06
PTB ratio
1.831.753.294.824.06
EV to sales
3.112.7424.34.423.47
Enterprise value over EBITDA
-24.163.61-7.986.5-10.4
EV to operating cash flow
6.15-3-5.03-11.45-5.53
EV to free cash flow
-7.04-2.47-4.92-10.82-5.16
Earnings yield
-0.05-0.26-0.17-0.38-0.04
Free cash flow yield
-0.08-0.23-0.17-0.08-0.17
Debt to equity
0.090.120.410.780.77
Debt to assets
0.050.060.170.20.22
Net debt to EBITDA
20.73-2.731.61-1.241.77
Current ratio
1.953.711.733.383.73
Interest coverage
-132.61-2.02-11.97-2.19-12.21
Income quality
-1.680.811.110.334.3
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.590.551.320.290
Research and developement to revenue
0.021.033.881.041.08
Intangibles to total assets
0.240.150.170.010
Capex to operating cash flow
-1.870.220.020.060.07
Capex to revenue
-0.95-0.2-0.11-0.02-0.05
Capex to depreciation
-3.96-0.2-0.29-0.02-0.46
Stock based compensation to revenue
0.060.040.220.090
Graham number
4.796.314.754.381.17
ROIC
-0.11-0.08-0.4-0.2-0.11
Return on tangible assets
-0.07-0.27-0.26-0.48-0.04
Graham Net
0.710.21-0.36-0.30.02
Working capital
115.78M126.64M58.37M98.49M108.38M
Tangible asset value
120.45M109.69M63.25M52.6M51.49M
Net current asset value
53.66M21.88M-21.8M-13.88M15.72M
Invested capital
0.090.120.410.780.77
Average receivables
79.89M17.42M20.06M28.38M46.95M
Average payables
34.81M28.74M29.06M24.74M18.96M
Average inventory
2.8M2.8M-2.47M-2.47M-1000
Days sales outstanding
69.54139.33555.09281.96390.71
Days payables outstanding
225.83.54K221.88147.740
Days of inventory on hand
45.260-38.41-0.010
Receivables turnover
5.252.620.661.290.93
Payables turnover
1.620.11.652.470
Inventory turnover
8.063.04M-9.5-25.83K0
ROE
-0.1-0.45-0.55-1.83-0.15
Capex per share
-0.98-0.14-0.02-0.01-0.03

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.080.10.230.440
Net income per share
-0.41-0.80.010.020
Operating cash flow per share
-0.13-0.25-0.07-0.140
Free cash flow per share
-0.13-0.26-0.07-0.150
Cash per share
1.281.271.031.110
Book value per share
0.680.680.670.720
Tangible book value per share
0.660.660.660.710
Share holders equity per share
0.680.680.670.720
Interest debt per share
0.490.530.410.510
Market cap
167.23M263.84M230.56M231.32M0
Enterprise value
83.01M221.86M159.14M200.57M-30.71M
P/E ratio
-1.3-1.0267.133.660
Price to sales ratio
27.6831.7511.476.540
POCF ratio
-16.42-13.06-40.22-20.180
PFCF ratio
-16.33-12.62-39.16-19.640
P/B Ratio
3.094.873.9840
PTB ratio
3.094.873.9840
EV to sales
13.7426.77.925.67-1.85
Enterprise value over EBITDA
-7.54-8.4112.95-124.731.95
EV to operating cash flow
-8.15-10.98-27.76-17.491.46
EV to free cash flow
-8.1-10.61-27.03-17.031.33
Earnings yield
-0.19-0.2400.010
Free cash flow yield
-0.06-0.08-0.03-0.050
Debt to equity
0.720.780.60.70.77
Debt to assets
0.190.20.170.20.22
Net debt to EBITDA
7.651.59-50.6819.131.95
Current ratio
3.383.383.843.843.73
Interest coverage
0-306.430-16.21-11.35
Income quality
0.320.31-6.67-6.672.27
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.840.610.220.130
Research and developement to revenue
2.213.030.780.81.48
Intangibles to total assets
0.010.01000
Capex to operating cash flow
0.010.030.030.030.1
Capex to revenue
-0.01-0.08-0.01-0.01-0.12
Capex to depreciation
-0.05-0.29-0.08-0.09-1.41
Stock based compensation to revenue
0.140.10.030.020
Graham number
2.53.490.390.590
ROIC
-0.13-0.2800.03-0.12
Return on tangible assets
-0.16-0.3100.01-0.05
Graham Net
-0.63-0.29-0.58-0.170
Working capital
98.49M98.49M106.79M106.79M108.38M
Tangible asset value
52.6M52.6M56.96M56.96M51.49M
Net current asset value
-13.88M-13.88M3.27M3.27M15.72M
Invested capital
0.720.780.60.70.77
Average receivables
22.46M20.71M20.64M29.25M0
Average payables
13.29M17.28M15.39M14.43M0
Average inventory
0.5-999.5-1000-3.24M0
Days sales outstanding
45.88415.3513.14141.49301.99
Days payables outstanding
92.04140.9456.47108.680
Days of inventory on hand
0-0.010-37.050
Receivables turnover
1.960.226.850.640.3
Payables turnover
0.980.641.590.830
Inventory turnover
13.35M-6.68K0-2.430
ROE
-0.59-1.190.010.03-0.18
Capex per share
0-0.01000

IPH.PA Frequently Asked Questions

What is Innate Pharma S.A. stock symbol ?

Innate Pharma S.A. is a FR stock and trading under the symbol IPH.PA

What is Innate Pharma S.A. stock quote today ?

Innate Pharma S.A. stock price is $2.19 today.

Is Innate Pharma S.A. stock public?

Yes, Innate Pharma S.A. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap